<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2015</study_start_year><condition>Circulating Tumor Cells</condition><condition>Neoplastic Cells, Circulating</condition><condition>Epithelial-Mesenchymal Transition</condition><disease>Circulating Tumor Cells</disease><disease>Neoplastic Cells, Circulating</disease><disease>Epithelial-mesenchymal Transition</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2202184</full_dataset_link><location>China</location><study_start_month>11</study_start_month><keyword>Aspirin</keyword><keyword>Metastatic breast cancer</keyword><keyword>Metastatic colorectal cancer</keyword><repository>ECRIN MDR</repository><study_status>Not provided</study_status></additional><is_claimable>false</is_claimable><name>Aspirin on CTCs of Advanced Breast and Colorectal Cancer</name><description>The purpose of this study is to determine whether Aspirin could affect the number and subtype of circulating tumor cells of metastatic breast cancer and colorectal cancer.</description><dates><creation>2015-11-15</creation></dates><accession>2202184</accession><cross_references><ClinicalTrials___gov>NCT02602938</ClinicalTrials___gov></cross_references></HashMap>